EGM
INDV icon

Engineers Gate Manager’s Indivior Pharmaceuticals INDV Stock Holding History

Engineers Gate Manager’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,273
Closed -$1.23M – 2415
2026
Q1 		$1.23M Buy
40,273
+170
+0.4% +$5.61K 0.02% 941
2025
Q4 		$1.44M Sell
40,103
-239
-0.6% -$7.3K 0.02% 861
2025
Q3 		$973K Buy
40,342
+6,540
+19% +$137K 0.01% 1169
2025
Q2 		$498K Buy
33,802
+10,018
+42% +$117K 0.01% 1482
2025
Q1 		$227K Sell
23,784
-3,446
-13% -$36.2K ﹤0.01% 1837
2024
Q4 		$338K Sell
27,230
-5,631
-17% -$57.9K 0.01% 1649
2024
Q3 		$320K Buy
+32,861
New +$385K 0.01% 1591

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's INDV Position: Q2 2026 in Review

Engineers Gate Manager sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 40,273 shares — an estimated $1.23M sold.

Engineers Gate Manager first reported a position in INDV in Q3 2024 and held it in 7 quarters. The position peaked at $1.44M in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Engineers Gate Manager reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 40,273 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.23M.
  • Engineers Gate Manager first reported a position in Indivior Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • Engineers Gate Manager's Indivior Pharmaceuticals position peaked at $1.44M in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.